La mayor parte de los estudios con glucocorticoides inhalados (GCI) realizados en pacientes con Enfermedad Pulmonar Obstructiva Crónica (EPOC) en la. Efecto de los glucocorticoides inhalados en la composición corporal del niño con asma moderada. Luis Aldamiz-Echevarría Azuaraa, Eduardo González. Los Corticosteroides Inhalados (ICSs). En cada embarazo, la mujer inicia con un 3 al 5 por ciento de probabilidad de tener un bebé con malformaciones.
|Published (Last):||22 November 2004|
|PDF File Size:||14.11 Mb|
|ePub File Size:||20.13 Mb|
|Price:||Free* [*Free Regsitration Required]|
Se establecieron dos grupos de sujetos: El tratamiento con beclometasona durante 3 meses no modifica los episodios de sibilancias durante el tratamiento ni en los glucocoeticoides meses siguientes.
Riesgos de los glucocorticoides inhalados en el asma infantil | Archivos de Bronconeumología
Multicentric, single-blind, glucocoryicoides, randomised intervention study. We established two groups of patients: We compared the number of wheezing episodes and their severity during the intervention period 3 months and the follow-up period 12 months with the Student’s t-test and the Chi-squared test.
There were no significant differences between the treatment and the control group in the study periods. Inhaled glucocorticoidez given for 3 months does not significantly modify the occurrence of inhslados episodes during the treatment period or during the following 12 months.
Inhaled corticosteroids and wheezing post-bronchiolitis. Aizpurua GaldeanoI. Ozcoidi ErroL. Mancisidor AguinagaldeC.
Guedea AdiegoE. Busselo OrtegaI. Servicio Vasco de Salud-Osakidetza. Conclusiones El tratamiento con beclometasona durante 3 meses no modifica los episodios de sibilancias durante el tratamiento ni en los 12 meses siguientes. Design Multicentric, single-blind, controlled, randomised intervention study. Intervention We established two groups of patients: We compared the number of wheezing episodes and their severity during the intervention period 3 months and the follow-up period 12 months with the Student’s t-test and the Chi-squared test.
There were no significant differences between the treatment and the control group in the study periods. Conclusions Inhaled beclomethasone given for 3 months does not significantly modify the occurrence of wheezing episodes during the treatment period or during the following 12 months.
Bronchiolitis as a possible cause of wheezing in childhood: Pediatrics, 74pp. Continuing respiratory problems three and a half years after acute viral bronchiolitis. Arch Dis Child, 60pp.
Respiratory status and allergy after bronchiolitis. Arch Dis Child, 67pp. Long-term prospective study in children after respiratory syncytial virus infection.
J Pediatr,pp. Am J Dis Child,pp. Diminished lung function as a predisposing factor for wheezing respiratory illness in infants.
N Engl J Med,pp. Airway responsiveness in infants following bronchiolitis.
Monografías de Archivos de Bronconeumología
Pediatr Pulmonol, 13pp. The relationship of respiratory infections in early childhood to the occurrence of increased levels of bronchial responsiveness and atopy. Am Rev Respir Dis,pp.
Respiratory syncytial virus-specific IgE antibody responses at the mucosal surface: Adv Glucocorticoidees Med Biol,pp. The predictive relationship between serum IgE levels at birth and subsequent incidences of lower respiratory illnesses and eczema in infants.
Thorax, 49pp. Inhaled budesonide for treatment of recurrent wheezing in early childhood. Lancet,pp. The functional response of infants with persistent wheezing to nebulized beclomethasone dipropionate.
Pediatr Pulmonol, glucocorticoodespp. Inhaled budesonide for chronic inhaaldos under 18 months of age. Randomised controlled trial of budesonide for the prevention of post-bronchiolitis wheezing. Arch Dis Child, 80pp. Early nebulized budesonide in the treatment of bronchiolitis and the prevention of postbronchiolitic wheezing.
One-year follow-up of young children hospitalized for wheezing: Pediatr Pulmonol, 26pp. Anti-inflammatory therapy reduces wheezing after bronchiolitis.
Arch Pediatr Glucocogticoides Med,pp. Comparison of two nebulized treatments in wheezing infants. European Respir J, Ipp. Serum immunoglobulin E in atopic and non-atopic children aged 6 months to 5 years. Acta Paediatr Scand, 71pp. Prevalencia y factores de riesgo de asma en Guipuzcoa. An Esp Pediatr, 43pp. Nebulised beclomethasone dipropionate in recurrent obstructive episodes after acute bronchiolitis. Arch Dis Child, 63pp. Pediatr Pulmonol, 22pp. Bronchiolitis and asthma in infancy and glucoxorticoides childhood.
Respiratory syncytial glucocorticoires in early life and risk of wheeze and allergy by age 13 years. Apneas en lactantes con bronquiolitis: Si continua navegando, consideramos que acepta su uso.
To improve our services and products, we use “cookies” own or third parties authorized to show advertising related to client preferences through the analyses of navigation customer behavior. Continuing navigation will be considered as acceptance of this use. You can change the settings or obtain more information by clicking here. Are you a health professional able to prescribe or dispense drugs?